Literature DB >> 215914

Reduction of angiotensin-converting enzyme in substantia nigra in early-onset schizophrenia.

A Arregui, A V MacKay, L L Iversen, E G Spokes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 215914     DOI： 10.1056/NEJM197903013000921

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Angiotensin I converting enzyme gene polymorphisms and risk of psychiatric disorders.

Authors:  Mohammadarian Akbari; Reyhane Eghtedarian; Bashdar Mahmud Hussen; Solat Eslami; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  BMC Psychiatry       Date:  2022-05-23       Impact factor: 4.144

Review 2.  Proteases of human brain.

Authors:  A Pope; R A Nixon
Journal:  Neurochem Res       Date:  1984-03       Impact factor: 3.996

3.  Protease activities in normal and schizophrenic human prefrontal cortex and white matter.

Authors:  A Pope; J A Amelotte; H Belfer; R A Nixon
Journal:  Neurochem Res       Date:  1981-10       Impact factor: 3.996

4.  Association between Insertion/Deletion Polymorphism in Angiotension Converting Enzyme and Susceptibility to Schizophrenia.

Authors:  Hajar Mazaheri; Mostafa Saadat
Journal:  Iran J Public Health       Date:  2015-03       Impact factor: 1.429

5.  Convergent evidences from human and animal studies implicate angiotensin I-converting enzyme activity in cognitive performance in schizophrenia.

Authors:  A Gadelha; A M Vendramini; C M Yonamine; M Nering; A Berberian; M A Suiama; V Oliveira; M T Lima-Landman; G Breen; R A Bressan; V Abílio; M A F Hayashi
Journal:  Transl Psychiatry       Date:  2015-12-08       Impact factor: 6.222
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.